Cegedim Strategic Data appoints global research director

FRANCE— Cegedim Strategic Data (CSD) has appointed Anne-Marie Masquelier as global medical research director where she will oversee the firm’s medical research activities.

Masquelier, a doctor specialising in endocrinology, who moved into the business side of the healthcare industry with senior management roles at biotech companies Genethon, GenoSafe, Aster-Cephac and MDS Pharma Services.

At Cegedim she will be responsible for developing the firm’s medical research activities and strategies, which include clinical, observational and epidemiological studies.

She will also manage and reinforce the firm’s research teams in France, Germany, Spain, China, Japan, the US and the UK.

Cegedim Strategic Data CEO Bruno Sarfati said: “I am delighted to welcome Anne-Marie to CSD. Her medical expertise and vast management experience in pharmaceutical, clinical and biotech organisations is ideal for the future development of CSD’s global medical research offer.”

We hope you enjoyed this article.
Research Live is published by MRS.

The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.

Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.

For example, there's an archive of winning case studies from over a decade of MRS Awards.

Find out more about the benefits of joining MRS here.

0 Comments


Display name

Email

Join the discussion

Newsletter
Stay connected with the latest insights and trends...
Sign Up
Latest From MRS

Our latest training courses

Our new 2025 training programme is now launched as part of the development offered within the MRS Global Insight Academy

See all training

Specialist conferences

Our one-day conferences cover topics including CX and UX, Semiotics, B2B, Finance, AI and Leaders' Forums.

See all conferences

MRS reports on AI

MRS has published a three-part series on how generative AI is impacting the research sector, including synthetic respondents and challenges to adoption.

See the reports

Progress faster...
with MRS 
membership

Mentoring

CPD/recognition

Webinars

Codeline

Discounts